PRJNA721806
Heparanase: A potential marker of worse prognosis in estrogen receptor-positive breast cancer
Heparanase promotes tumor growth in breast tumors. We now evaluated heparanase protein and gene expression status and investigated its impact on disease-free survival in order to gain better insight into the role of heparanase in ER-positive (ER+) breast cancer prognosis and to clarify its role in cell survival following chemotherapy.